Abstract
Background: There is no information in the literature concerning the use of cytoreductive surgery with intraperitoneal chemotherapy for sarcomas disseminated intraabdominally.
Methods: A prospective study was initiated of exploratory laparotomy, removal of all macroscopic tumor when feasible, and intraperitoneal chemotherapy with cis-DDP 100 mg/m2 every 4 weeks. Patients were to be explored in 6 months or earlier for detectable tumor recurrence. Twenty-eight consecutive patients enrolled in the study.
Results: Complete resection of all macroscopic tumor was possible in 79% of patients. Survival rates at years 1–5 were 54%, 21%, 7%, 7%, and 7%, respectively. Of the two long-term survivors, one was found to be disease free at the second-look operation with a catheter free of adhesions, whereas the other had recurrent disease and all her lesions were resected. Of 20 patients who underwent a second-look procedure, the Tenkhoff intraperitoneal catheter was found to be densely surrounded by adhesions in 19. In the 19 patients with adhesions, there was no tumor around the catheter for a radius of 15–20 cm, but the rest of the peritoneal cavity contained multiple tumor nodules.
Conclusion: Removal of all macroscopic tumor is possible in 79% of the patients with sarcoma disseminated in the abdominal cavity. Intraperitoneal chemotherapy with cis-DDP after cytoreductive surgery resulted in a 5-year survival rate of only 7%.
Similar content being viewed by others
References
Karakousis CP, Blumenson LE, Canavese G, Rao U. Surgery for disseminated abdominal sarcoma.Am J Surg 1992;163:560–4.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–86.
Lawrence W Jr, Donegan WL, Nachimuth N, et al. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons.Ann Surg 1987;205:349–59.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karakousis, C.P., Kontzoglou, K. & Driscoll, D.L. Intraperitoneal chemotherapy in disseminated abdominal sarcoma. Annals of Surgical Oncology 4, 496–498 (1997). https://doi.org/10.1007/BF02303674
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303674